Management of the High-Risk Lupus Pregnant Patient

Rheumatic Disease Clinics of North America

Volumn 33, Issue 2, 2007, Pages 253-265

  Witter, Frank R ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AZATHIOPRINE; BETAMETHASONE; CYCLOPHOSPHAMIDE; DALTEPARIN; DEXAMETHASONE; DIPEPTIDYL CARBOXYPEPTIDASE; ENOXAPARIN; FUROSEMIDE; HEPARIN; HYDRALAZINE; HYDROXYCHLOROQUINE; LABETALOL; LOW MOLECULAR WEIGHT HEPARIN; LUPUS ANTICOAGULANT; METHYLDOPA; NIFEDIPINE; PHOSPHOLIPID ANTIBODY; PREDNISONE; WARFARIN;

CAUSE OF DEATH; CONGENITAL HEART BLOCK; DRUG SUBSTITUTION; FETUS GROWTH; HIGH RISK PATIENT; HUMAN; INCIDENCE; INTRAUTERINE GROWTH RETARDATION; KIDNEY FAILURE; LETHALITY; LUPUS ERYTHEMATOSUS NEPHRITIS; MATERNAL HYPERTENSION; MATERNAL WELFARE; MORBIDITY; NEPHROLOGIST; OBSTETRICS; PATIENT ASSESSMENT; PREECLAMPSIA; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURITY; PREVALENCE; PRIORITY JOURNAL; REVIEW; RHEUMATOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS;

ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; FEMALE; HUMANS; HYPERTENSION; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PREGNANCY, HIGH-RISK; PREMATURE BIRTH; PRENATAL CARE; STILLBIRTH;

EID: 34248232513     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rdc.2007.02.002     Document Type: Review

References (54)

1. Buyon J.P. The effects of pregnancy on autoimmune disease. J Leukoc Biol 63 (1998) 281-287
2. CDC. Trends in deaths from systemic lupus erythematosus-United States, 1979-1998. MMWR Morb Mortal Wkly Rep 51 (2002) 371-374
3. Yasmeen S., Walkins E.E., Field N.T., et al. Pregnancy outcomes in women with systemic lupus erythematosus. J Matern Fetal Med 10 (2001) 91-96
4. Reddy U., and Rossiter J. Preconception, prenatal care and breastfeeding in Lambrou NC. In: Morse A.N., and Wallach E.E. (Eds). The Johns Hopkins Manual of Gynecology and Obstetrics (1999), Lippincott and Williams, Philadelphia 5-17
5. Hayslett J.P., and Lynn R.L. Effect of pregnancy in patients with lupus nephritis. Kidney International 18 (1980) 207-220
6. Julkunen H. Pregnancy and lupus nephritis. Scand J Urol Nephrol 35 4 (2001) 319-327
7. Bobie G., Liote F., Houillier P., et al. Pregnancy in lupus nephritis and related disorders. Am J Kidney Dis 9 (1987) 339-343
8. Fine L.G., Barnett E.U., Danovitch G.M., et al. Systemic lupus erythematosus in pregnancy. Ann Intern Med 9 (1981) 667-677
9. Petri M. Systemic lupus erythematosus and pregnancy. Rheum Dis Clin North Am 20 (1994) 87-118
10. Hou S.H., Grossman S.D., and Madias N.E. Pregnancy in women with renal disease and moderate renal insufficiency. Am J Med 78 (1985) 105-194
11. Mechen R.T., and Dorsey K. Pregnancy among patients with systemic lupus erythematosus receiving immunosuppressive therapy. J Rheumatol 14 (1987) 252-258
12. The American College of Obstetricians and Gynecologists. Diagnosis and management of preeclampsia and eclampsia (2006), 2006 Compendium of Selective Publications, Washington, DC
13. Simpson L.L. Maternal medical disease: risk of antepartum fetal death. Semin Perinatol 26 (2002) 42-50
14. Petri M., and Allbritton J. Fetal outcome of lupus pregnancy: a retrospective case-control study of the Hopkins lupus cohort. J Rheumatol 20 (1993) 650-656
15. Gimovsley M.L., Motoro M., and Paul R.H. Pregnancy outcome in women with system lupus erythematosus. Obstet Gynecol 63 (1984) 686-692
16. Hytten F.E., and Leitch I. The physiology of human pregnancy. 2nd edition (1971), Blackwell Scientific Publications, London p. 80-3, 146-7
17. Buyon J.P., Cronstein B.N., Morris M., et al. Serum complement values (C3 and C4) to differentiate between systemic lupus activity and pre-eclampsia. Am J Med 81 (1986) 194-200
18. Sanchez-Ramos L., Jones D.C., and Cullen M.T. Urinary calcium as an early marker for preeclampsia. Obstet Gynecol 77 (1991) 685-688
19. Ramsey-Goldman R., Kutzer J.E., Kuller L.H., et al. Previous pregnancy outcome is an important determinant of subsequent pregnancy outcome in women with systemic lupus erythematosus. Am J Reprod Immunol 28 (1992) 195-198
20. Mintz G., Niz J., Gutierrez G., et al. Prospective study of pregnancy in systemic lupus erythematosus. Results of a multidisciplinary approach. J Rheumatol 13 (1986) 732-739
21. Kiss E., Bhattoa H.P., Bettembuk P., et al. Pregnancy in women with systemic lupus erythematosus. Eur J Obstet Gynecol Reprod Biol 101 2 (2002) 129-134
22. Hayslett J.P. The effect of systemic lupus erythematosus on pregnancy and pregnancy outcome. Am J Reprod Immunol 28 3-4 (1992) 199-204
23. Oshiro B.T., Silver R.M., Scott J.R., et al. Antiphospholipid antibodies and fetal death. Obstet Gynecol 87 4 (1996) 489-493
24. Petri M., Howard D., Repke J., et al. The Hopkins Lupus Pregnancy Center: 1987-1991 update. Am J Reprod Immunol 28 3-4 (1992) 188-191
25. Clowse M.E., Magder L.S., Witter F., et al. Early risk factors for pregnancy loss in lupus. Obstet Gynecol 107 2 Pt 1 (2006) 293-299
26. Clowse M.E.B., Magder L.S., Witter F., et al. The impact of increased lupus activity on obstetric outcomes. Arthritis Rheum 52 2 (2005) 514-521
27. Johnson M.J., Petri M., Witter F.R., et al. Evaluation of preterm delivery in a systemic lupus erythematosus pregnancy clinic. Obstet Gynecol 86 3 (1995) 396-399
28. The American Academy of Pediatrics and the American College of Obstetricians and Gynecologists. Antepartum care. In: Guidelines for perinatal care. 5th edition. Washington, DC: The American Academy of Pediatrics and the American College of Obstetricians and Gynecologists; 2002. p. 73-127.
29. The American College of Obstetricians and Gynecologists. Intrauterine growth restriction. Washington, DC: 2006 Compendium of Selected Publications; 2006.
30. The American College of Obstetricians and Gynecologists. Chronic hypertension in pregnancy. Washington, DC: 2006 Compendium of Selected Publications; 2006.
31. The American College of Obstetricians and Gynecologists. Ultrasound in pregnancy (2006), 2006 Compendium of Selected Publications, Washington, DC
32. Harman C.R. Assessment of fetal health. In: Creasy R.K., Resnik R., and Iams J.D. (Eds). Maternal-fetal medicine principles and practice. 5th edition (2004), Saunders, Philadelphia 357-401
33. DiPetro J., Caulfield L., Costigan K., et al. Fetal neurobehavioral development: a tale of two cities. Dev Psychol 40 3 (2004) 445-456
34. Resnik R., and Creasy R.K. Intrauterine growth restriction. In: Creasy R.K., Resnik R., and Iams J.D. (Eds). Maternal-fetal medicine principles and practice. 5th edition (2004), Saunders, Philadelphia 495-512
35. Buyon J.R., Waltuck J., Kleinman C., et al. In Utero identification and therapy of congenital heart block. Lupus 4 (1995) 116-121
36. Reed K.L., Anderson C.F., and Shenker L. Fetal cardiac arrhythmias. Fetal echocardiography (1988), Wiley-List, New York 115-124
37. Barbui T., Cortelazzo S., Galli M., et al. Antiphospholipid antibodies in early repeated abortions: a case-controlled study. Fertil Steril 50 (1988) 589-592
38. Rai R.S., Clifford K., Cohen H., et al. High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies. Hum Reprod 10 12 (1995) 3301-3304
39. Balasch J., Creus M., Fabregues F., et al. Antiphospholipid antibodies and human reproductive failure. Hum Reprod 11 10 (1996) 2310-2315
40. MacLean M.A., Cumming G.P., McCall F., et al. The prevalence of lupus anticoagulant and anticardiolipin antibodies in women with a history of first trimester miscarriages. Br J Obstet Gynaecol 101 (1994) 103-106
41. Parazzini F., Acaia B., Faden D., et al. Antiphospholipid antibodies and recurrent abortion. Obstet Gynecol 77 6 (1991) 854-858
42. Parke A.L., Wilson D., and Maier D. The prevalence of antiphospholipid antibodies in women with recurrent spontaneous abortions, women with successful pregnancies, and women who have never been pregnant. Arthritis Rheum 34 10 (1991) 1231-1235
43. The American College of Obstetricians and Gynecologists. Antiphospholipid syndrome (2006), 2006 Compendium of Selected Publications, Washington, DC
44. Pattison N.S., Chamley L.W., Birdsall M., et al. Does aspirin have a role in improving pregnancy outcome for women with antiphospholipid syndrome? A randomized controlled trial. Am J Obstet Gynecol 183 (2000) 1008-1012
45. Empson M., Lassere M., Craig J.C., et al. Recurrent pregnancy loss with antiphospholipid antibody: a systemic review of therapeutic trials. Obstet Gynecol 99 1 (2002) 135-144
46. Sephton V., Farquharson R.G., Topping J., et al. A longitudinal study of maternal dose response to low molecular weight heparin in pregnancy. Obstet Gynecol 101 (2003) 1307-1311
47. Mercer B.M. Assessment and induction of fetal pulmonary maturity. In: Creasy R.K., Resnik R., and Iams J.D. (Eds). Maternal-fetal medicine principles and practice. 5th edition (2004), Saunders, Philadelphia 451-463
48. Clowse M.E.B., Magder L., Witter F., et al. Hydroxchloroquine in lupus pregnancy. Arthritis Rheum 54 (2006) 3640-3647
49. Khamashta M.A., Buchanan N.M.M., and Hughes G.R.V. The use of hydroxychloroquine in lupus pregnancy-the British experience. Lupus 5 Suppl 1 (1996) 565-566
50. The Canadian Hydroxycholorquine Group. A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythmatous. N Engl J Med 324 (1991) 150-154
51. Levy R.A., Vilela V.S., Cataldo M.J., et al. Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study. Lupus 10 (2001) 401-404
52. Sibai B.M., Grossman R.A., and Grossman H.G. Effects of diuretics on plasma volume in pregnancy with long term hypertension. Am J Obstet Gynecol 150 (1984) 831-835
53. Briggs G.G., Freeman R.K., and Yaffe S.J. Drugs in pregnancy and lactation. 7th edition (2005), Lippincott Williams & Wilkins, Philadelphia p. 136-9, 209-17, 397-404, 705-7, 1145-8
54. Sibai B.M., Mabie W.C., Samsa F., et al. A comparison of no medication versus ethyldopa of labetalol to chronic hypertension during pregnancy. Am J Obstet Gynecol 162 (1990) 960-967